⏳ Fetching live dividend data...
Home › Calculator › BTTAY Dividend Calculator 2026
Biotest AG · OTC
Price: $24.21 · Annual div: $24.90/share · Frequency: annual · Payout ratio: 999% · Ex-div: 2026-06-11
BTTAY (Biotest AG) has a dividend yield of 102.88%, based on an annual dividend of $24.90 per share and a price of $24.21. Over the last 12 months it paid $24.90 per share — a trailing yield of 102.88%. Dividends are paid annual.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-06-11Latest | — | $24.9033 | — | — |
| 2025-07-07 | 2025-07-22 | $0.0138 | — | — |
Operating globally from its headquarters in Dreieich, Germany, Biotest AG is a pharmaceutical company established in 1946. It specializes in the research, development, manufacturing, and commercialization of biological medicines. The company's operations are structured across its Therapy, Plasma & Services, and Other divisions. Biotest's product portfolio addresses critical needs within hematology, clinical immunology, and intensive care medicine. For instance, Biotest provides treatments for hemophilia, including Haemoctin and Vihuma for hemophilia A, and Haemonine for hemophilia B, addressing both acute episodes and long-term prevention. Its infectious disease portfolio features therapies like Cytotect CP for cytomegalovirus, Varitect for varicella zoster virus, and several Hepatitis B-related products such as Fovepta (for neonate prophylaxis), Hepatect (reinfection prophylaxis), and Zutectra (post-liver transplant reinfection prevention). For immune system disorders and certain neurological conditions, Biotest offers Intratect and IgG Next Generation, targeting primary and secondary antibody deficiencies, and autoimmune diseases. Additionally, Biotest produces Albiomin and Biseko for plasma volume restoration, alongside Cofact and Fibrinogen to address various clotting factor deficiencies, including congenital fibrinogen deficiency. Specialized treatments further comprise Trimodulin for community-acquired pneumonia and COVID-19, and Pentaglobin for bacterial infections. Initially established as Biotest Serum-Institut GmbH, the company adopted its current name, Biotest Aktiengesellschaft, in 1986. As of January 21, 2022, Biotest AG functions as a subsidiary of Grifols, S.A.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BTTAY position with:
Real after-tax yield depends on where you live and how you hold BTTAY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 102.88% | 100.08% | $10,288 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 87.45% | 84.65% | $8,745 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 82.30% | 79.50% | $8,230 / yr |
| 🇬🇧 UK ISA | 0% | 102.88% | 100.08% | $10,288 / yr |
| 🇬🇧 UK Taxable | 8.75% | 93.88% | 91.08% | $9,388 / yr |
| 🇨🇦 TFSA | 0% | 102.88% | 100.08% | $10,288 / yr |
| 🇨🇦 CA Taxable | 25% | 77.16% | 74.36% | $7,716 / yr |
| 🇦🇺 Super (pension) | 15% | 87.45% | 84.65% | $8,745 / yr |
| 🇦🇺 AU Taxable | 30% | 72.02% | 69.22% | $7,202 / yr |
| 🇩🇪 DE Taxable | 26.375% | 75.75% | 72.95% | $7,575 / yr |
| 🇫🇷 FR Taxable | 30% | 72.02% | 69.22% | $7,202 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $24.90/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
BTTAY pays annually — 1 payment per year.
How BTTAY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BTTAY sourced from FMP /financial-growth endpoint — real data, not estimates.
Compare BTTAY with peers: BTTAY vs CKDXF · BTTAY vs CLAZF · BTTAY vs CSWYF
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BTTAY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Biotest AG (BTTAY) is currently trading at $24.21, trading near its 52-week high. The current dividend yield is 102.88% based on an annual payout of $24.90 per share.
Biotest AG (BTTAY) is a healthcare stock currently trading at $24.21 with a dividend yield of 102.88%. It pays an annual dividend of $24.90 per share. The payout ratio of 999% indicates investors should monitor dividend sustainability. Over the past 5 years, BTTAY has grown its dividend at a compound annual rate of 16.3%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.
At a 102.88% yield, reinvesting every payout is not a realistic long-term assumption — payouts this high rarely last and the share price usually falls as they are paid, so we don't model DRIP growth for BTTAY.
BTTAY (Biotest AG) has a dividend yield of 102.88%, based on an annual dividend of $24.90 per share and a price of $24.21. Over the last 12 months it paid $24.90 per share — a trailing yield of 102.88%. Dividends are paid annual.
$10,000 in BTTAY at a 102.88% yield pays about $10,288 a year ($857 a month) before taxes. Payouts this high rarely last — don't count on this income continuing at today's rate.
At a 102.88% yield, reinvesting every payout is not a realistic long-term assumption — payouts this high rarely last and the share price usually falls as they are paid, so we don't model DRIP growth for BTTAY.
Enter your starting amount, monthly contribution and time horizon in the BTTAY DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
BTTAY's next ex-dividend date has not been announced yet; the most recent one was 2026-06-11. BTTAY pays dividends annual. Buy before the ex-dividend date to receive the next payment.
BTTAY has less than a year of dividend history in our data, so there is no dividend growth rate yet.
BTTAY pays out 999% of its earnings as dividends. A payout ratio above 80% means the dividend depends on earnings holding up. Dividends can be cut at any time; this is not financial advice.
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever